Yinan Liu

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients

Shang‐Gin Wu, Yinan Liu, Meng‐Feng Tsai et al. · Oncotarget · 2016 · 234 citations · Full text

Osimertinib as neoadjuvant therapy in patients with EGFR-mutant resectable stage II-IIIB lung adenocarcinoma (NEOS): A multicenter, single-arm, open-label phase 2b trial

Chao Lv, Wentao Fang, Nan Wu et al. · Lung Cancer · 2023 · 101 citations · Full text

IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer

Yinan Liu, Tzu‐Hua Chang, Meng‐Feng Tsai et al. · Oncotarget · 2015 · 86 citations · Full text

Expression of inflammatory cytokines in serum and peritoneal fluid from patients with different stages of endometriosis

Yanyan Fan, Hongyu Chen, Wei Chen et al. · Gynecological Endocrinology · 2018 · 83 citations

Clinical and the Prognostic Characteristics of Lung Adenocarcinoma Patients with ROS1 Fusion in Comparison with Other Driver Mutations in East Asian Populations

Yen‐Fu Chen, Min‐Shu Hsieh, Shang‐Gin Wu et al. · Journal of Thoracic Oncology · 2014 · 81 citations

Ros1 Fusion, Oncology, East Asian Populations +10